Latest news
ADVENZYMES: Q1 FY27 revenue up 2% year-over-year, but EBITDA and PAT declined amid margin pressure - TradingViewTradingView · Sat, 08 Aug 2026 12:00:17 GMTAdvanced Enzyme Approves Buyback At ₹500 Per Share Amid Q1 Profit Of ₹37.1 Crore - SahiSahi · Sat, 08 Aug 2026 09:42:31 GMTADVENZYMES: Q1 FY27 saw profit growth, a ₹697M buyback, and strategic investments in subsidiaries - TradingViewTradingView · Sat, 08 Aug 2026 09:01:00 GMTBIKAJI Stock Price and Chart — NSE:BIKAJI - TradingViewTradingView · Wed, 05 Aug 2026 05:09:38 GMTAdvanced Enzyme Technologies Ltd Revenue Breakdown – NSE:ADVENZYMES - TradingViewTradingView · Mon, 27 Jul 2026 10:28:01 GMT